98 related articles for article (PubMed ID: 9828821)
1. Mutations of p53 gene can be detected in the plasma of patients with large bowel carcinoma.
Mayall F; Jacobson G; Wilkins R; Chang B
J Clin Pathol; 1998 Aug; 51(8):611-3. PubMed ID: 9828821
[TBL] [Abstract][Full Text] [Related]
2. Molecular detection of APC, K- ras, and p53 mutations in the serum of colorectal cancer patients as circulating biomarkers.
Wang JY; Hsieh JS; Chang MY; Huang TJ; Chen FM; Cheng TL; Alexandersen K; Huang YS; Tzou WS; Lin SR
World J Surg; 2004 Jul; 28(7):721-6. PubMed ID: 15185002
[TBL] [Abstract][Full Text] [Related]
3. A rapid and nonisotopic method for the screening and sequencing of p53 gene mutations in formalin-fixed, paraffin-embedded tumors.
Soong R; Iacopetta BJ
Mod Pathol; 1997 Mar; 10(3):252-8. PubMed ID: 9071734
[TBL] [Abstract][Full Text] [Related]
4. Genetic diversity at the p53 locus between primary human colorectal adenocarcinomas and their lymph-node metastases.
Zhang JS; Caplin S; Bosman FT; Benhattar J
Int J Cancer; 1997 Mar; 70(6):674-8. PubMed ID: 9096648
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality.
Al-Mulla F; Going JJ; Sowden ET; Winter A; Pickford IR; Birnie GD
J Pathol; 1998 Jun; 185(2):130-8. PubMed ID: 9713338
[TBL] [Abstract][Full Text] [Related]
6. Mutations of the tumour suppressor gene p53 in colorectal and hepatocellular carcinomas.
Shi CY; Phang TW; Wee A; Ngoi SS; Lin Y; Li B; Ong CN; Lee HP
Ann Acad Med Singap; 1995 Mar; 24(2):204-10. PubMed ID: 7653961
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance in molecular detection of p53 mutation in serum of patients with colorectal carcinoma.
Ito T; Kaneko K; Makino R; Konishi K; Kurahashi T; Ito H; Katagiri A; Kushima M; Kusano M; Mitamura K; Imawari M
Oncol Rep; 2003; 10(6):1937-42. PubMed ID: 14534722
[TBL] [Abstract][Full Text] [Related]
8. Reduced messenger RNA expression level of p21 CIP1 in human colorectal carcinoma tissues and its association with p53 gene mutation.
Matsushita K; Kobayashi S; Kato M; Itoh Y; Okuyama K; Sakiyama S; Isono K
Int J Cancer; 1996 Aug; 69(4):259-64. PubMed ID: 8797864
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
10. Characterization of p53 gene mutations in colorectal carcinomas from an Asian population.
Shi CY; Phang TW; Ngoi SS; Wee A; Li B; Lin Y; Lee HP; Ong CN
Anticancer Res; 1994; 14(6B):2811-6. PubMed ID: 7872723
[TBL] [Abstract][Full Text] [Related]
11. Specific p53 gene mutations in urinary bladder epithelium after the Chernobyl accident.
Yamamoto S; Romanenko A; Wei M; Masuda C; Zaparin W; Vinnichenko W; Vozianov A; Lee CC; Morimura K; Wanibuchi H; Tada M; Fukushima S
Cancer Res; 1999 Aug; 59(15):3606-9. PubMed ID: 10446970
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of p53 abnormalities in colorectal carcinoma detected by PCR-SSCP and immunohistochemical analysis.
Leahy DT; Salman R; Mulcahy H; Sheahan K; O'Donoghue DP; Parfrey NA
J Pathol; 1996 Dec; 180(4):364-70. PubMed ID: 9014855
[TBL] [Abstract][Full Text] [Related]
13. p53 gene mutation, microsatellite instability and adjuvant chemotherapy: impact on survival of 388 patients with Dukes' C colon carcinoma.
Elsaleh H; Powell B; Soontrapornchai P; Joseph D; Goria F; Spry N; Iacopetta B
Oncology; 2000; 58(1):52-9. PubMed ID: 10644941
[TBL] [Abstract][Full Text] [Related]
14. Telomerase activity and p53 gene mutation in familial polyposis coli.
Ikeguchi M; Makino M; Kaibara N
Anticancer Res; 2000; 20(5C):3833-7. PubMed ID: 11268463
[TBL] [Abstract][Full Text] [Related]
15. Mutation of the p53 gene precedes aneuploid clonal divergence in colorectal carcinoma.
Carder PJ; Cripps KJ; Morris R; Collins S; White S; Bird CC; Wyllie AH
Br J Cancer; 1995 Feb; 71(2):215-8. PubMed ID: 7841032
[TBL] [Abstract][Full Text] [Related]
16. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M
Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113
[TBL] [Abstract][Full Text] [Related]
17. p53 gene point mutations in relation to p53 nuclear protein accumulation in colorectal cancers.
Costa A; Marasca R; Valentinis B; Savarino M; Faranda A; Silvestrini R; Torelli G
J Pathol; 1995 May; 176(1):45-53. PubMed ID: 7616356
[TBL] [Abstract][Full Text] [Related]
18. [Detection of p53 mutation using PCR-SSCP silver staining method].
Zhao W; Si J; Li K; Zhang X; Song G
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Jun; 17(3):219-22. PubMed ID: 8706159
[TBL] [Abstract][Full Text] [Related]
19. Microsatellite instability and p53 mutations in sporadic right and left colon carcinoma: different clinical and molecular implications.
Lleonart ME; García-Foncillas J; Sánchez-Prieto R; Martín P; Moreno A; Salas C; Ramón y Cajal S
Cancer; 1998 Sep; 83(5):889-95. PubMed ID: 9731891
[TBL] [Abstract][Full Text] [Related]
20. [The methodological specificity of PCR-test of gene p53 in plasma and blood cell DNA of oncological patients].
Bartnovskiĭ AE; Belokhvostov AS; Abramov AA; Likhin FA
Klin Lab Diagn; 2003 Nov; (11):19-23. PubMed ID: 14708367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
